Diploma (LON:DPLM) Upgraded to “Outperform” at Royal Bank Of Canada

Royal Bank Of Canada upgraded shares of Diploma (LON:DPLM) to an outperform rating in a report released on Friday morning, Marketbeat reports. Royal Bank Of Canada currently has GBX 6,000 price objective on the stock, up from their prior price objective of GBX 4,500.

Several other equities research analysts have also commented on DPLM. Shore Capital reiterated a “hold” rating and set a GBX 5,100 price target on shares of Diploma in a research note on Thursday, July 17th. JPMorgan Chase & Co. reiterated a “neutral” rating and set a GBX 4,440 price target on shares of Diploma in a research note on Wednesday, August 6th. Jefferies Financial Group lifted their price target on shares of Diploma from GBX 4,500 to GBX 5,200 and gave the stock a “hold” rating in a research note on Thursday, September 11th. Finally, Berenberg Bank lifted their price target on shares of Diploma from GBX 5,750 to GBX 6,350 and gave the stock a “buy” rating in a research note on Wednesday, September 10th. Three analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of GBX 5,365.

Diploma Price Performance

Shares of LON:DPLM opened at GBX 5,362.50 on Friday. The company’s fifty day moving average price is GBX 5,387.22 and its 200 day moving average price is GBX 4,740.59. Diploma has a 12 month low of GBX 3,532 and a 12 month high of GBX 5,625. The company has a debt-to-equity ratio of 62.17, a current ratio of 2.17 and a quick ratio of 0.80. The firm has a market capitalization of £7.19 billion, a P/E ratio of 4,314.16, a P/E/G ratio of 2.82 and a beta of 0.75.

About Diploma

Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, Continental Europe, North America, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies technology-enabled products used in surgical procedures in operating theatres and endoscopy; testing equipment and services for clinical laboratories; and bio-pharma, food safety and testing, and other research-oriented products.